Insider at

04

Insider transactions

05
0 buys (P) 0 sells (S) Net: $0 + 15 non-open-market transactions below last 12 months, based on the transactions shown below

Price change vs current quote, split-adjusted for corporate actions since the filing — not benchmarked, not annualized, not size-weighted

15 other filings hidden
DateTickerCodeSharesPriceValue Owned afterΔ ownA/Dvs now
Feb. 2, 2023 VRDN S 10b5-1 50,000 $36.80 $1,840,000 480,905 Direct -9.42% Disposed -47.3% (price as of 2026-10-02)
Feb. 2, 2023 VRDN S 10b5-1 50,000 $36.80 $1,840,000 430,905 Direct -10.40% Disposed -47.3% (price as of 2026-10-02)
June 1, 2022 VRDN S 10b5-1 30,000 $12.20 $366,000 480,905 Direct -5.87% Disposed 59.0% (price as of 2026-10-02)
May 2, 2022 VRDN S 10b5-1 30,000 $13.04 $391,200 510,905 Direct -5.55% Disposed 48.8% (price as of 2026-10-02)
April 4, 2022 VRDN S 10b5-1 3,600 $18.93 $68,148 540,905 Direct -0.66% Disposed 2.5% (price as of 2026-10-02)
April 1, 2022 VRDN S 10b5-1 26,400 $18.92 $499,488 544,505 Direct -4.62% Disposed 2.5% (price as of 2026-10-02)
March 2, 2022 VRDN S 10b5-1 11,106 $17.36 $192,800 570,905 Direct -1.91% Disposed 11.8% (price as of 2026-10-02)
March 1, 2022 VRDN S 10b5-1 18,894 $17.82 $336,691 582,011 Direct -3.14% Disposed 8.9% (price as of 2026-10-02)
Feb. 3, 2022 VRDN S 10b5-1 909 $19.16 $17,416 600,905 Direct -0.15% Disposed 1.3% (price as of 2026-10-02)
Feb. 2, 2022 VRDN S 10b5-1 12,340 $18.47 $227,920 601,814 Direct -2.01% Disposed 5.0% (price as of 2026-10-02)
Feb. 1, 2022 VRDN S 10b5-1 16,751 $19.55 $327,482 614,154 Direct -2.66% Disposed -0.8% (price as of 2026-10-02)

P = Open-market purchase · S = Sale · A = Grant/award · M = Option exercise · G = Gift · F = Tax withholding

Insider transactions are not a recommendation; sales are often driven by liquidity or tax reasons.

Derivative holdings (Form 4 Table II) Options, RSUs and convertible securities reported on Form 4 Table II.

06
DateTickerSecurityUnderlying Exercise priceExpirationSharesA/D
June 2, 2026 CBIO Stock Option (Right to Buy) Ordinary Shares (11,050) $17.01 June 2, 2036 11,050 Acquired
May 21, 2026 DNTH Stock Option (Right to Buy) Common Stock (6,090) $89.63 May 21, 2036 6,090 Acquired
June 23, 2025 CBIO Stock Option (Right to Buy) Ordinary Shares (9,023) $15.30 June 23, 2035 9,023 Acquired
May 22, 2025 DNTH Stock Option (Right to Buy) Common Stock (12,500) $18.36 May 22, 2035 12,500 Acquired
May 23, 2024 DNTH Stock Option (Right to Buy) Common Stock (11,000) $21.77 May 22, 2034 11,000 Acquired
Sept. 11, 2023 DNTH Stock Option (Right to Buy) Common Stock (6,500) $11.20 Sept. 10, 2033 6,500 Acquired
Feb. 2, 2023 VRDN Stock Option (Right to Buy) Common Stock (50,000) $0.15 Sept. 23, 2030 50,000 Disposed
Feb. 2, 2022 VRDN Stock Option (Right to Buy) Common Stock (280,000) $18.51 Feb. 2, 2032 280,000 Acquired
Dec. 8, 2021 VRDN Series A Non-Voting Convertible Preferred Stock Common Stock (627,564) · · 9,413 Disposed
Jan. 18, 2021 VRDN Employee Stock Option (right to buy) Common Stock (800,075) $23.03 Jan. 17, 2031 800,075 Acquired
Oct. 27, 2020 VRDN Series A Non-Voting Convertible Preferred Stock Common Stock (9,413,000) · · 9,413 Acquired
Oct. 27, 2020 VRDN Employee Stock Option (Right to Buy) Common Stock (4,338,079) $0.01 Sept. 23, 2030 4,338,079 Acquired

Exercise/conversion price is blank when not applicable (e.g. RSUs).

Initial ownership (Form 3) 8 holdings

07

Securities held when first becoming an insider, per SEC Form 3.

DateTickerSecuritySharesOwnership
Sept. 10, 2026 KRSA Common Stock 207,400 Direct
Sept. 10, 2026 KRSA Stock Option (Right to Buy)→ Common Stock (1,048,244) 1,048,244 Direct
Sept. 10, 2026 KRSA Stock Option (Right to Buy)→ Common Stock (1,984,157) 1,984,157 Direct
June 23, 2025 CBIO Ordinary Shares · Direct
June 23, 2025 CBIO Stock Option (Right to Buy)→ Ordinary Shares (226,786) 226,786 Direct
Oct. 30, 2020 VRDN Common Stock 50,124 Direct
Oct. 30, 2020 VRDN Employee Stock Option (Right to Buy)→ Common Stock (4,338,079) 4,338,079 Direct
Oct. 30, 2020 VRDN Series A Non-Voting Convertible Preferred Stock→ Common Stock (9,413,000) 9,413,000 Direct

Compensation (DEF 14A)

08

Matched by name from proxy statements (DEF 14A) — verify against the filing.

Fiscal yearSalaryBonusStock awards Option awardsNon-equity incentivePension changeOtherTotal
2023 $59,209 · · · · · $564,712 $2,211,072
2022 $601,200 $288,576 · · · · $2,320 $4,646,740
2021 $567,000 $408,240 · · · · $9,021 $17,408,538

Figures from the Summary Compensation Table of the company's proxy statement (DEF 14A). Compensation is not a recommendation.